Journal Title：Biomarkers In Medicine

Biomarkers are physical, functional or biochemical indicators of physiological or disease processes. These key indicators can provide vital information in determining disease prognosis, in predicting of response to therapies, adverse events and drug interactions, and in establishing baseline risk. The explosion of interest in biomarker research is driving the development of new predictive, diagnostic and prognostic products in modern medical practice, and biomarkers are also playing an increasingly important role in the discovery and development of new drugs. For the full utility of biomarkers to be realized, we require greater understanding of disease mechanisms, and the interplay between disease mechanisms, therapeutic interventions and the proposed biomarkers. However, in attempting to evaluate the pros and cons of biomarkers systematically, we are moving into new, challenging territory.

Biomarkers in Medicine (ISSN 1752-0363) is a peer-reviewed, rapid publication journal delivering commentary and analysis on the advances in our understanding of biomarkers and their potential and actual applications in medicine. The journal facilitates translation of our research knowledge into the clinic to increase the effectiveness of medical practice.

As the scientific rationale and regulatory acceptance for biomarkers in medicine and in drug development become more fully established, Biomarkers in Medicine provides the platform for all players in this increasingly vital area to communicate and debate all issues relating to the potential utility and applications.

Each issue includes a diversity of content to provide rounded coverage for the research professional. Articles include Guest Editorials, Interviews, Reviews, Research Articles, Perspectives, Priority Paper Evaluations, Special Reports, Case Reports, Conference Reports and Company Profiles. Review coverage is divided into themed sections according to area of therapeutic utility with some issues including themed sections on an area of topical interest.

Biomarkers in Medicine provides a platform for commentary and debate for all professionals with an interest in the identification of biomarkers, elucidation of their role and formalization and approval of their application in modern medicine. The audience for Biomarkers in Medicine includes academic and industrial researchers, clinicians, pathologists, clinical chemists and regulatory professionals.

生物標志物是生理或疾病過程的物理、功能或生化指標。這些關(guān)鍵指標可為確定疾病預(yù)后、預(yù)測對治療的反應(yīng)、不良事件和藥物相互作用以及確定基線風(fēng)險提供重要信息。人們對生物標志物研究興趣的激增推動了現(xiàn)代醫(yī)療實踐中新型預(yù)測、診斷和預(yù)后產(chǎn)品的開發(fā)，生物標志物在新藥的發(fā)現(xiàn)和開發(fā)中也發(fā)揮著越來越重要的作用。為了充分發(fā)揮生物標志物的效用，我們需要更好地了解疾病機制以及疾病機制、治療干預(yù)措施和擬議的生物標志物之間的相互作用。然而，在嘗試系統(tǒng)地評估生物標志物的優(yōu)缺點時，我們正在進入新的、充滿挑戰(zhàn)的領(lǐng)域。

《醫(yī)學(xué)中的生物標志物》（ISSN 1752-0363）是一本同行評審的快速出版期刊，提供有關(guān)我們對生物標志物的理解進展及其在醫(yī)學(xué)中的潛在和實際應(yīng)用的評論和分析。該期刊有助于將我們的研究知識轉(zhuǎn)化為臨床應(yīng)用，從而提高醫(yī)療實踐的有效性。

隨著生物標志物在醫(yī)學(xué)和藥物開發(fā)中的科學(xué)原理和監(jiān)管認可度越來越充分，《生物標志物在醫(yī)學(xué)中》為這一日益重要的領(lǐng)域的所有參與者提供了一個平臺，以交流和討論與潛在效用和應(yīng)用有關(guān)的所有問題。

每期都包含各種內(nèi)容，為研究專業(yè)人士提供全面的報道。文章包括客座社論、訪談、評論、研究文章、觀點、優(yōu)先論文評估、特別報告、病例報告、會議報告和公司簡介。評論報道根據(jù)治療效用領(lǐng)域分為主題部分，有些期刊包括關(guān)于熱門領(lǐng)域的主題部分。

《生物標志物在醫(yī)學(xué)中》為所有對生物標志物的識別、其作用的闡明以及其在現(xiàn)代醫(yī)學(xué)中的應(yīng)用的正規(guī)化和批準感興趣的專業(yè)人士提供了一個評論和辯論的平臺。 《醫(yī)學(xué)生物標志物》的受眾包括學(xué)術(shù)和工業(yè)研究人員、臨床醫(yī)生、病理學(xué)家、臨床化學(xué)家和監(jiān)管專業(yè)人員。

Biomarkers In Medicine創(chuàng)刊于2007年，由Future Medicine Ltd.出版商出版，收稿方向涵蓋醫(yī)學(xué) - 醫(yī)學(xué)：研究與實驗全領(lǐng)域，此期刊水平偏中等偏靠后，在所屬細分領(lǐng)域中專業(yè)影響力一般，過審相對較易，如果您文章質(zhì)量佳，選擇此期刊，發(fā)表機率較高。平均審稿速度 較慢,6-12周 ，影響因子指數(shù)1.9，該期刊近期沒有被列入國際期刊預(yù)警名單，廣大學(xué)者值得一試。